Two Sigma Securities, LLC Indaptus Therapeutics, Inc. Transaction History
Two Sigma Securities, LLC
- $716 Million
- Q4 2024
A detailed history of Two Sigma Securities, LLC transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 16,620 shares of INDP stock, worth $12,465. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,620Holding current value
$12,465% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
20Shares Held
638KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$192,1980.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$75,1320.0% of portfolio
-
Geode Capital Management, LLC Boston, MA82.1KShares$61,5880.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$34,0020.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ43.9KShares$32,9400.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $6.19M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...